http://ijaprs.com/index.php/ijapr/issue/feedInternational Journal of Ayurveda and Pharma Research2025-03-16T11:04:13+08:00Dr B Srinivasulu M.D (Ayu.)ijaprs@gmail.comOpen Journal Systems<div align="justify"> <p class="para1"><strong>International Journal of Ayurveda and Pharma Research (IJAPR)</strong> is an international peer reviewed Monthly open access Online and Print journal. The aim of the journal is to increase the impact of research in both academic and industry, with strong emphasis on quality and originality. The journal promotes to publish the articles in the field of <strong>Ayurveda, Siddha, Yoga, Naturopathy, Unani, Homeopathy and Allopathy</strong> systems of medicine and Pharmaceutical Sciences. Researchers may submit (1). Original Research Articles (2). Review articles (3). Book Reviews (4). Short Communications/ Research Letter (5). Case Report (6). Letter to the Editor/Correspondence.</p> </div>http://ijaprs.com/index.php/ijapr/article/view/3583A Comparative Standard Manufacturing procedure of Swarjika Kshara prepared from Ushtrapriya (Fagonia cretica Linn.) and Rudanti (Cressa cretica Linn.)2025-03-15T21:13:12+08:00Janaki Pateljanaki7775@gmail.comBharat Kalsariyajanaki7775@gmail.com<p><em>Swarjika Kshara</em> is a significant alkaline formulation in Ayurveda, traditionally prepared using plants like <em>Ushtrapriya</em> (<em>Fagonia cretica Linn.</em>) and <em>Rudanti</em> (<em>Cressa cretica Linn.</em>). Classical references such as <em>Rasatarangini</em> and<em> Ayurvediya Rasashastra</em> describe the preparation of <em>Kshara</em>, while modern practices often substitute it with chemically synthesized sodium bicarbonate. The Ayurvedic Pharmacopeia of India (API) lacks specific standards for plant-origin <em>Swarjika Kshara,</em> necessitating a study to develop and standardize its manufacturing process. <strong>Aim</strong>: To develop a Standard Manufacturing Procedure (SMP) for <em>Swarjika Kshara</em> prepared from <em>Ushtrapriya</em> and <em>Rudanti</em>. <strong>Material and Methods</strong>: Three batches of <em>Swarjika</em> <em>Kshara</em> were prepared from <em>Ushtrapriya</em> and <em>Rudanti</em> following classical references. Pharmaceutical observations were recorded, and standardized batches were produced to validate uniformity. Yield percentages, ash content, and procedural differences were analyzed. <strong>Results</strong>: The study found significant differences in yield, with <em>Rudanti</em> (47.41%) producing more than double the <em>Kshara</em> compared to <em>Ushtrapriya</em> (18.46%). Both samples were successfully standardized, and uniform operative procedures were established. <strong>Conclusion</strong>: The study validated SMP for <em>Swarjika Kshara</em> from <em>Ushtrapriya</em> and <em>Rudanti</em>, ensuring consistency in production. The findings offer a foundation for large-scale manufacturing and future research, addressing the gap in API standards for plant-origin <em>Swarjika Kshara.</em></p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3572Pharmaceutical Standardization and Preliminary Analysis of Vishatindukadi Vati Prepared by two References2025-03-15T21:13:12+08:00Patel Rimpaldrrimpalpatel29@gmail.comKalsariya Bharatdrrimpalpatel29@gmail.com<p>Standardization of herbo-mineral drugs is essential to certify their quality, purity and reproducibility. <em>Vishatindukadi</em> <em>Vati</em> is a herbo-mineral formulation mentioned in Rasatantrasaara and Siddhaprayoga Sangraha (RTSSPS) with two references and different ingredients. The formulation mentioned in <em>Gutika</em> <em>Prakarana</em> contains <em>Kupilu</em> (<em>Strychnos nux- vomica </em>Linn), <em>Maricha</em> (<em>Piper</em> <em>nigrum</em> Linn.), <em>Puga Phala </em>(<em>Araca catechu </em>Linn<em>.</em>) and<em> Chincha Beeja </em>(<em>Tamarindus indica </em>Linn). while the formulation mentioned in <em>Vatavyadhi</em> <em>Prakarana</em> contains <em>Kupilu</em> (<em>Strychnos nux-vomica </em>Linn<em>.</em>) and <em>Maricha</em> (<em>Piper nigrum </em>Linn<em>.</em>) with <em>Bhavana</em> of <em>Nagavalli</em> (<em>Piper</em> <em>betel </em>Linn<em>.</em>) <em>Patra</em> <em>Svarasa</em>. It is mentioned in context of various diseases i.e., <em>Jirna</em> <em>Vatavyadhi </em>(chronic disorders due to <em>Vata</em>), <em>Jirna</em> <em>Jvara</em> (chronic fever)<em>,</em> <em>Ajirna </em>(indigestion), <em>Mandagni </em>(subdued digestive power) and many more. In pharmaceutical process; 3 batches of <em>Kupilu Shodhana</em> and using both references three batches of <em>Vishatindukadi</em> <em>Vati</em> were prepared and its organoleptic and physico-chemical analysis were performed. Organoleptic and physicochemical analysis of raw materials, in-process and finished products were done. In physico-chemical pH, loss on drying at 105°C, total ash (%w/w), acid insoluble ash (%w/w), water-soluble extractive (%w/w), alcohol soluble extractive (%w/w), uniformity of weight (mg), friability (%), hardness (kg/cm<sup>2</sup>) and disintegration time (min.) were carried out for VTV1 and VTV2. An average value of VTV1 and VTV2 were 5.3, 6.48%, 1.55%, 0.24%, 22.5%, 6.96%, 124.3mg, 0.16%, 4.6kg/cm<sup>2</sup>, 37.6min and 5.05, 7.24%, 2.39%, 0.26%, 23.7%, 6.69%, 124mg, 0.14%, 3.63kg/cm<sup>2</sup> and 32 min. respectively. It needs further preclinical and clinical studies to prove its safety profile and therapeutic efficacy.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3584A Comparative Clinical Study of Trikatu Churna and Pippali Churna in Artavakshaya w.s.r. to PCOS2025-03-15T21:13:12+08:00K. Rohitharohitha929@gmail.comG. Swarupa Ranigattusr135@gmail.comA. Vijaya Lakshmivijayalakshmiayanam@gmail.com<p><em>Artavakshaya,</em> a condition described in Ayurveda, is characterised by scanty and irregular menstruation, which closely correlates with the Polycystic Ovary Syndrome (PCOS). PCOS is a common endocrine disorder affecting reproductive-aged women, leading to menstrual irregularities, anovulation, and metabolic disturbances. <em>Trikatu Churna</em>, a combination of <em>Pippali (Piper longum</em> Linn.<em>), Maricha (Piper nigrum </em>Linn.<em>), </em>and <em>Shunti (Zingiber officinale </em>Roscoe.<em>)</em>, is known for its <em>Deepana</em>, <em>Pachana</em> and <em>Kaphavatahara</em> properties, which may help in correcting metabolic imbalances associated with PCOS. <em>Pippali Churna</em> is recognized for its <em>Rasayana</em> and <em>Lekhana</em> actions, which may aid in improving ovarian function and hormonal balance. This study aims to compare the clinical efficacy of <em>Trikatu Churna</em> and <em>Pippali Churna</em> in managing <em>Artavakshaya</em> for PCOS. The effects of both formulations were evaluated based on clinical parameters such as duration of bleeding, irregular menstruation, amount of bleeding and quantity of menstrual blood, pain during the menstruation, hirsutism and BMI. This comparative clinical study was conducted on a total of 40 patients diagnosed with PCOS presenting with <em>Artavakshaya </em>symptoms and were randomly divided into two groups. Group A received <em>Trikatu Churna</em>, and Group B received <em>Pippali Churna</em> for 90 days. The primary outcome measures included improvements in duration of bleeding, irregular menstruation, amount of bleeding and quantity of menstrual blood, and pain during the menstrual period. The secondary outcomes included improvements in hirsutism and BMI. Both treatments showed significant improvements in the management of PCOS symptoms. However, <em>Trikatu Churna</em> was found to be slightly more effective in regulating menstrual cycles. This study suggests that <em>Trikatu Churna</em> and <em>Pippali Churna</em> can be beneficial in the management of <em>Artavakshaya</em> associated with PCOS, with <em>Trikatu Churna</em> showing marginally superior efficacy.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3529Effect of Chavyadi Masthu and Selected Yoga Techniques in Obesity2025-03-15T22:16:21+08:00Dhiya Georgedr.diya.binu@gmail.comJyothi. Rdrjyothisajeev@gmail.comNafeesath Beevi. Aanafeesathbeevi@gmail.com<p>Obesity is a complex multi-factorial disease and a major risk factor for many non-communicable diseases which invites several pathological complications. Obesity is defined as abnormal or excessive fat accumulation that may impair health. The prevalence of obesity is now rapidly increasing worldwide due to increased sedentary lifestyles, physical inactivity, and unhealthy diets. Eating more calories than one burn in daily activity on a long-term basis causes the extra calories to add up and cause obesity. By proper Ayurvedic management which includes lifestyle modification in the form of a healthy diet and regular exercises like <em>Yoga</em>, the burden of obesity can be reduced. In this study, an Ayurvedic dietary formulation, <em>Chavyadi Masthu</em> and practice of selected <em>Yogasanas </em>were taken as interventions. 31 obese participants between the age group of 25 and 50 were selected and administered <em>Chavyadi Masthu </em>preparation with regular practice of selected <em>Yoga </em>techniques for 3 months. BMI, waist circumference, hip circumference, waist hip ratio and skin-fold thickness were assessed on 0<sup>th</sup>, 31<sup>st</sup>, 61<sup>st</sup>, 91<sup>st</sup> days along with lipid profile and FBS on 0<sup>th</sup> and 91<sup>st</sup> day. Analysis of data revealed that the interventions were effective in reducing body mass index, waist-hip ratio, waist circumference, hip circumference, skin-fold thickness, total cholesterol, serum triglyceride, LDL and VLDL and FBS levels and improvement in HDL with a significant level p<0.05.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3530Effect of Yava Syamaka Peya and Suryanamaskara in Overweight Adults2025-03-15T21:13:12+08:00V Greeshmagreeshmav6991@gmail.comJyothi Rdrjyothisajeev@gmail.comA. Nafeesath Beevianafeesathbeevi@gmail.com<p>Overweight refers to abnormal or excessive fat accumulation that presents a risk to health. Overweight is currently widespread in both developed and developing countries, affecting both children and adults. A higher prevalence is observed among individuals of high socioeconomic status, particularly in urban areas. Modern lifestyles and poor dietary habits are the primary factors contributing to the development of overweight. If not managed promptly, overweight can progress to obesity, leading to a host of pathological complications. The management of overweight should focus on promoting appropriate dietary choices and boosting energy expenditure through physical activity. <em>Yava Syamaka Peya</em> mentioned in <em>Bhavaprakasha Nighantu</em> was adopted as a dietary intervention. Along with this diet, <em>Suryanamaskara </em>was made into the daily routine of participants for a period of 3 months. The intervention, consisting of 300ml of <em>Yava Syamaka peya</em> along with the daily practice of 12 rounds of <em>Suryanamaskara</em>, was conducted in 31 subjects. The results were analysed using the paired t-test and repeated measures ANOVA test. The study found a considerable reduction in body weight, with an average loss of 6.65 kg over 3 months. Participants experienced an average decrease of 2.645 kg/m² in BMI and a reduction of 0.035 in the waist-hip ratio. Additionally, FBS decreased by 14.71 mg/dl, and total cholesterol levels dropped by an average of 23.42 mg/dl. These results were statistically significant. From this, it is concluded that the intake of <em>Yava Syamaka peya</em> along with the practice of <em>Suryanamaskara</em> for 3 months is effective in reducing overweight.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3569The Therapeutic Potential of Lashuna (Allium sativum) in Gynecological Disorders: An Integrative Review2025-03-15T21:13:12+08:00Divya Rani.S.Rdivyasus.sr@gmail.com<p><em>Lashuna </em>(<em>Allium sativum</em>), commonly known as garlic, holds a significant place in Ayurvedic medicine for its diverse therapeutic properties. This review aims to integrate classical Ayurvedic references with contemporary scientific research to evaluate the efficacy of <em>Lashuna </em>in managing gynecological disorders, including premenstrual syndrome (PMS), polycystic ovary syndrome (PCOS), vaginal infections, and menopausal symptoms. Ayurvedic texts such as the <em>Charaka Samhita</em> and <em>Sushruta Samhita</em> describe <em>Lashuna</em> as a potent <em>Rasayana </em>with <em>Vata-Kapha</em> pacifying, digestive stimulant, and antimicrobial properties, making it beneficial for reproductive health. Modern studies corroborate these claims, demonstrating garlic's antimicrobial, anti-inflammatory, and hormonal regulatory effects. Clinical trials have reported significant reductions in PMS symptoms and improvements in insulin resistance among PCOS patients following garlic supplementation. Additionally, garlic exhibits antimicrobial activity against pathogens responsible for vaginal infections and may offer cardiovascular and antioxidant benefits pertinent to menopausal women. While these findings are promising, further rigorous clinical trials are necessary to establish standardized guidelines for <em>Lashuna'</em>s therapeutic application in gynecological health.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3586Management of Sandhivata (Osteoarthritis) by an Ayurvedic Compound Drug2025-03-15T21:13:13+08:00Srivastava Vijay Kumarsrivast_25@yahoo.comSrivastava Anubhasrivast_25@yahoo.com<p><em>Sandhivata</em> (osteoarthritis) is a disease of old age people and usually hampering the working hours and quality of life in number of peoples worldwide. We have found this Ayurvedic treatment very effective in the management of this disease. Hence a time bound clinical research work was framed for objective assessment of the improvement. The study was performed on osteoarthritis of knee joint over fifty patients. The diagnostic and assessment criteria were mainly clinical, along with visual analogue scale for pain and Algo Functional Lequesne Index (Knee) to assess the severity of knee osteoarthritis. The symptoms included were pain, swelling, stiffness, tenderness, joint crepitus and decreased movement. The drugs <em>Sanjeevani vati</em>, <em>Dashamula kwatha, Punarnava mandura</em> and <em>Yava kshara</em> were given for thirty days, with one follow up at fifteen days. There was a drop out of four patients during the trial. The pain (2.18±0.72), stiffness (1.93±0.72) and restriction of movements (2.28±0.81) are the three major complaints followed by crepitus (1.82±0.72), tenderness (1.43±1.10) and swelling (1.29±1.01). The initial score of severity of the disease was 9.75<u>+</u>4.16; which was reduced to 6.20<u>+</u>4.33 after 15 days and it was 3.49<u>+</u>1.16 at the end of the trial, this also gives a highly significant ‘t’ and ‘p’ score i.e. 15.11 and p< 0.001 respectively. So, the effect of combined therapy was evaluated moderate to high in reducing severity of disease. Some patient even told that they have felt relief in symptoms just on the 2<sup>nd</sup> day after starting the treatment.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3525Ayurvedic Management of Non-Productive Cough in SSC- Interstitial Lung Disease2025-03-15T21:13:13+08:00Swathy Krishnaswathyponnuz.sp@gmail.comP M Madhudrpmmadhu@gmail.com<p>Interstitial lung diseases (ILDs) encompass a diverse group of disorders that affect the lung parenchyma or interstitium, leading to inflammation and progressive scarring of lung tissue. This process results in thickening and stiffening of the lung tissue, impairing the lungs' ability to expand and fill with air. As occupational disorders rise in society, particularly conditions like ILD, there is an increasing need for preventive healthcare approaches. While current invasive diagnostic methods and therapeutic interventions offer certain benefits, they often come with drawbacks such as side effects and high costs. Ayurvedic medicine, with its holistic focus on prevention and individualized treatment, offers a promising alternative. By addressing underlying imbalances and promoting overall wellness, Ayurvedic remedies could provide a feasible and effective solution for managing symptoms of ILD and preventing its progression, aligning with modern healthcare's push towards more natural and sustainable care practices.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3540Utility of Agnikarma in Day to-Day Practice2025-03-15T21:13:13+08:00Padmadrpadmabhats@gmail.comSrinivas Masalekardrpadmabhats@gmail.com<p><em>Agnikarma</em> is an important para surgical procedure used in Ayurveda widely accepted for pain management since ages. The therapy includes the controlled transfer of varied degree of heat to the affected part with wide therapeutic intentions. Acharya Sushruta, the pioneer of <em>Agnikarma</em> stresses on multifaceted utility of <em>Agnikarma</em> and mentioned that it could be a potential alternative when management using medicine surgery or <em>Kshara</em> fails. He claims non-recurrence of benign pathologies when treated by <em>Agnikarma</em>. Though one can be fascinated by these claims, deeper understanding of the procedure is much essential to achieve the success. As therapy requires fire which could be hazardous and end up in burns. Thus, it is very essential to analyze <em>Agnikarma vidhi</em> in depth and understand logic behind selection of ideal patient, choosing the right device and conducting the procedure without any un toward event with proper precautions. Also knowing the idea behind contraindications allows us to prevent complications in current era. So here is an attempt to understand the rationality behind the various steps included in <em>Agnikarma</em>.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3587Pharmacognostical Evaluation of Bhringaraja (Eclipta alba Hassk): An Ayurvedic Drug2025-03-15T21:13:13+08:00T. Srinivasdrsrinivasthandra@gmail.comA. Kavya Rashmikadrsrinivasthandra@gmail.comS. Babu Raodrsrinivasthandra@gmail.comG. Swarupa Ranidrsrinivasthandra@gmail.comA. Vijaya Laxmidrsrinivasthandra@gmail.com<p>This study explores the pharmacognostical properties of <em>Bhringaraja</em> (<em>Eclipta alba Hassk</em>) <em>churna</em>, an herb highly valued in Ayurvedic medicine for its therapeutic benefits. The primary aim is to authenticate the identity of <em>Bhringaraja churna</em> and assess its quality parameters through comprehensive macroscopic, microscopic, and physicochemical, phytochemical evaluations<strong>. Macroscopic Analysis</strong>: The macroscopic examination confirmed the characteristic features of <em>Bhringaraja</em>, such as its yellowish-brown color, fine texture, and characteristic earthy aroma and bitter taste. <strong>Microscopic Analysis:</strong> Leaf microscopy showed upper and lower epidermis, cuticle, hypodermis, collenchyma, simple trichome, vascular bundle phloem, proto and meta xylem. Affirming the herb's identity and physicochemical parameters: Various physicochemical parameters were measured, including moisture content, ash values, extract values, and pH. These parameters ensure the stability, and quality of the <em>Churna</em>. This study underscores the importance of pharmacognostical and phytochemical research in enhancing the understanding and application of traditional herbal medicines in contemporary healthcare.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3520A Clinical Trial to Evaluate the Combined Effect of Ekavimshatika Guggulu and Bala Taila Matra Vasti in Sciatica2025-03-15T21:13:13+08:00Aishwarya Paishwaryap7372@gmail.comArun Pratapaishwaryap7372@gmail.comAparna Chandranaishwaryap7372@gmail.com<p><em>Ekavimshatika Guggulu</em> is mentioned in <em>Bhavaprakasha Madhyamakhanda Kushta Adhyaya </em>and <em>Bala Taila</em> mentioned in <em>Bhela Samhita Vata Vyadhi Adhyaya</em>. Most of the drugs in <em>Ekavimshatika Guggulu</em> are of <em>Vata-kapha Shamana </em>and also mitigate<em> Gridhrasi </em>as per the <em>Phalasruthy. Bala Taila</em> is having <em>Vatahara</em> property and is <em>Balya </em>in nature<em>. Matra Vasti</em> possess the qualities of <em>Vata Anulomana</em> and <em>Snehana</em> properties. The study was an interventional study with pre and post-test, without control group. Subjects of either gender with age group 20-60 years registered in Pankajakasthuri Ayurveda Medical College & Post Graduate Centre, satisfying the inclusion and exclusion criteria were subjected to positive sampling and total of 27 subjects were selected and 27 subjects completed the clinical trial. The selected subjects were administered <em>Ekavimshatika Guggulu</em> in a dosage of 2 tablets orally thrice daily before food along with 75ml <em>Bala Taila</em> as <em>Matra Vasti</em> for 14 days. Assessment of the subjects was done on 0<sup>th</sup> day, 15<sup>th</sup> day and follow up done on 30<sup>th</sup> day with subjective and objective parameters. <strong>RESULTS: </strong>On analysing the results, it has been found that subjective parameters like tenderness, radiating pain, ODI scale, Sciatica Bothersomeness Index Scale, Sciatica Frequency Index Scale and objective parameters like SLR, Lessigues sign, also other parameters like <em>Gridhrasi lakshanas</em> got statistically significant improvement. Friedman test was used to assess the overall significance between three points. P-value <0.05 was found to be significant. Wilcoxon Sign Rank test was used to find out overall difference between before treatment and after follow up in subjective parameters. Significance in range of movements was assessed by repeated measures of Anova. <strong>CONCLUSION:</strong> Based on the observations and results of the clinical study, the alternate hypothesis, <em>Ekavimshatika Guggulu</em> and <em>Bala Taila</em> <em>Matra Vasti</em> is effective in the management of sciatica is accepted and null hypothesis is rejected.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3590Pharmaceutical Standardization and Analytical Assessment of Shunthyadi Tailam: A Comprehensive Study2025-03-15T21:13:13+08:00Nandurkar Vishal Marotraovishalnandurkar60691@gmail.comBhoyar Seema Prakashraovishalnandurkar60691@gmail.com<p><em>Shunthyadi tailam</em>, a classical Ayurvedic formulation as <em>Nasya </em>therapy mentioned in <em>Ashtang hrudaya</em> for therapeutic use in <em>Bhrushakshava. Bhrushakshava</em> can be compared to the acute phase of allergic rhinitis. This study focuses on its pharmaceutical preparation and analytical standardization, adhering to the guidelines of the Ayurvedic Pharmacopoeia of India. The formulation was subjected to organoleptic and physico-chemical evaluations to establish benchmark standards. Key parameters such as acid value, saponification value, iodine value, specific gravity and refractive index were analyzed. These findings provide a scientific foundation for future research and ensure the quality and consistency of <em>Shunthyadi tailam</em> in therapeutic applications.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3409A Single Arm Clinical Study to Evaluate the Efficacy of Katankateriyadi Kwatha in the Management of Madhumeha (Diabetes Mellitus Type-2)2025-03-16T11:04:13+08:00Ram Muddalkarsantosh.swami@sgrayurved.edu.inSantosh I Swamisantosh.swami@sgrayurved.edu.in<p><em>Madhumeha</em> is known to Indian system of medicine since time immemorial. Almost all texts available, however old contain one or another very lucid hint of <em>Prameha</em>. This along with all of its causes, etiopathognesis, symptomatology, treatment and complications are mentioned in all Ayurvedic texts written centuries ago. It’s inclusion in eight major diseases (<em>Astamahagada</em>) indicates the significance and gravity attributed to it. Here 40 cases of newly diagnosed type 2 diabetes mellitus in a patient who underwent 3 follow up i.e., 30<sup>th</sup>, 60<sup>th</sup>, 90<sup>th </sup>of <em>Katankateriyadi kwatha</em> delivered in 3 months is reported. The patient’s fasting blood glucose and post plasma blood glucose levels, as well as HbA1C level were decreased after treatment. Further-more, no adverse effects were observed. The results of this clinical study are encouraging and provide evidence supporting the effectiveness of <em>Katankateriyadi</em> <em>Kwatha</em> in reducing <em>Madhumha</em> (Diabetes Mellitus Type-2) in a patient.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3591Management of Pyogenic Granuloma on Eyelid through Chemical Cauterization (Kshara Karma)2025-03-15T21:13:13+08:00Jyothidrjyothipatilsugur@gmail.comVeerayya R Hiremathdrjyothipatilsugur@gmail.comShashikala Kdrjyothipatilsugur@gmail.comAnita Kulkarnidrjyothipatilsugur@gmail.comGururaj Ndrjyothipatilsugur@gmail.com<p>Pyogenic granuloma is an acquired benign vascular proliferation. Clinical features are rapid painless, red polypoid papule or nodule growth on skin or mucus. Both surgical and non-surgical treatments are advised for pyogenic granuloma. <em>Arsha vartma</em> is one among <em>Netraroga</em> explained in <em>Vartmagataroga’s</em> according to <em>Acharya</em> <em>Sushruta</em> <em>Arsha</em> <em>vartma</em> <em>tridoshaja chedana</em> <em>Sadhya</em> <em>vyadhi</em>, is characterized by the eruption of a small, rough, lesion in lid margin which resembles <em>Ervaru</em> <em>beeja</em> (size of the lesion is similar to Cucumber Melos seed) and mild pain. <em>Acharya Vagbhata</em> included few other clinical features like burning sensation, bleeding and cure even after removal. <strong>Objective</strong>: to see the effect of <em>Tilanala</em> <em>kshara</em> in pyogenic granuloma. <strong>Methods</strong>: A 32 years old male patient visited our OPD of <em>Shalakya Tantra,</em> SJGAMC, Koppal, with complaints of painless slow growing mass on right upper eyelid near lid margin, occasionally bleeding with trauma since 20 days. Patient was diagnosed as Pyogenic granuloma (<em>Arsha vartma</em>). Patient was treated with 1 sitting of <em>Tilanala</em> <em>Kshara</em> <em>Pratisarana</em> and <em>Jathyadhi ghrita ointment</em> for 7 days. <strong>Result</strong>: complete resolution of pyogenic granuloma was seen in 7 days <strong>Conclusion</strong>: <em>Chedana</em>, <em>Bhedana</em>, <em>Lekhana</em> <em>Dahana</em> <em>karma</em> of <em>kshara</em> have effect on pyogenic granuloma and prevent the recurrence.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3519An Experimental Study to Evaluate the Anti-Microbial Effect of Fumigation with Sarshapanimbadi Dhoopa2025-03-15T21:13:13+08:00Greeshma Mmgreeshma73@gmail.comA. Nafeesath Beevianafeesathbeevi@gmail.comRenjumol V. Sdr.renjumol@gmail.com<p>Nowadays rising airborne diseases are one of the major health concerns of the entire world. Prevalence of various respiratory diseases are increasing in persons exposing to contaminated environment. Therefore, disinfection of our environment is most important. In <em>Ayurveda, Dhoopana</em> is a method of disinfection. <em>Sarshapanimbadidhoopa </em>mentioned in <em>Sushruta Samhita</em> with ingredients <em>Sarshapa, Nimba, Saindhava</em> and <em>Ghrita </em>was selected for the study to evaluate its antimicrobial activity. Primarily Staphylococcus aureus and Candida albicans were identified from different treatment procedure rooms of hospital by placing petri dishes open for one hour with suitable medium. Fumigation of identified microbes were done within a glass chamber with and without adding <em>Dhoopanadravya</em> to red hot charcoal. In addition to that one set of microbial plate of bacteria and fungus were kept as such without fumigation for the assessment of efficacy of fumigation. Fumigation was done with varying doses (15g, 20g, 25g and 30g) and time span (5minutes, 10minutes, 15minutes and 20minutes). Results obtained were statistically analyzed using independent t-test, ANOVA test and paired t-test. Reduction in Colony Forming Unit (CFU) of bacteria and fungi were found to be significant and fumigation with adding <em>Dhoopachoorna</em> was found to be more significant than without adding <em>Dhoopachoorna</em> to charcoal. Complete cessation of bacterial CFU was found on fumigation with 30g <em>Choorna</em> for 20minutes and fungal CFU was found on fumigation of 25g <em>Choorna</em> for 15minutes. The study concluded that <em>Sarshapanimbadi Dhoopa</em> has antimicrobial effect.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3592Efficacy of Guduchyadi Yoga in the Management of Medoroga with special reference to Dyslipidemia- A Rondomized Clinical Trial2025-03-15T21:13:13+08:00Amrutha Yamrutha.y156@gmail.comSajjanar J Neelakantaneelkant.ayu@gmail.comKrishna Gopalagetgopee@outlook.com<p><em>Medoroga, </em>a condition which arises due to <em>Medo dhatu vriddhi </em>which may lead to <em>Bahutwa</em> and <em>Abaddhatwa</em> of <em>Poshaka medo dhatu.</em> It can be correlated to disease dyslipidemia based on pathophysiology. It is the need of the hour to contribute safer, effective and economical medicines to manage the condition. Main aim of the study was to evaluate the efficacy of <em>Guduchyadi yoga </em>and<em> Navaka Guggulu </em>in the management of <em>Medoroga </em>with special reference to dyslipidemia. <strong>Methods: </strong>The present study implemented an open-labelled, active controlled pre and post-test clinical study with 30 subjects (who fulfilled the diagnostic and inclusion criteria). A convenience sampling method was used for the selection. Subjects were randomly assigned into two groups, Group A (trial) and Group B (control) comprising of 15 subjects each. Subjects of Group A received <em>Guduchyadi Yoga </em>(50ml<em> Kashaya </em>with 1.5g of<em> Guggulu</em>) and Group B received <em>Navaka Guggulu </em>(2 tablets with warm water). Both interventions were given twice daily before food for duration of 30 days. A twelve-hour fasting sample of serum lipid profile and BMI were used to measure the efficacy before and after the treatment. Statistical analysis of parameters was assessed using Wilcoxon signed rank test (W), Friedman’s test, Mann Whitney U test (U), by paired t-test, repeated measures ANOVA test, unpaired t-test. <strong>Results: </strong>The trial drug showed statistically significant result in improving serum lipid profile and reducing BMI (P<0.05). <strong>Conclusion: </strong>The polyherbal formulation (<em>Guduchyadi yoga</em>) is effective in the management of <em>Medoroga </em>(dyslipidemia).</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3550A Clinical Study of Cumulative Effect of Shwadanstradi Tail Manyabasti and Nasya in the Management of Manyastambha with special reference to Cervical Spondylitis2025-03-15T22:22:51+08:00Pooja Chheniyadrpoojakukde@gmail.comLalit R Kukdedrkukdelalit@gmail.comSonal D Wankhedewankhedesonal18@gmail.com<p><em>Manyastambha</em> is a clinical condition of the neck region and is one of the prone disorders caused by vitiated <em>Vata</em> in working mid-aged population. Acharya Charak describes <em>Manyastambha</em> in eighty <em>Nanatamaj vatavyadhis</em>. However, As per modern science, <em>Manyastambha</em> can be correlated to cervical spondylosis. It is a common health problem encountered in practice whose prevalence increases with age, and is estimated to be around 95% by age 65. In this single arm pre-post experimental clinical study, without regard to sex, religion, or other factors, a total of 30 individuals with the defining signs and symptoms of <em>Manyastambha</em> were chosen for this research trial (cervical spondylitis). In the current study, <em>Shwadanstradi Tail Manya Basti </em>and <em>Nasya</em> as described by Acharya Charak in <em>Chikitsa sthana</em> were administered for 14 days, with a regular follow up of 8<sup>th</sup>, 14<sup>th</sup> and 21<sup>st</sup> days respectively without any internal medications and alteration in diet and lifestyle. Results showed that pain was reduced by 79.33% (VAS Scale), <em>Stambha</em>/stiffness 57.47%, and total neck mobility by 56.44% which were statistically significant. Statistically very significant results were also found in neck flexion (64.13%), neck extension (52.38%) and passive neck flexion (52.27%). Thus, conservative cumulative management of <em>Manyabasti</em> and <em>Nasya</em> of <em>Shwadanshtradi</em> <em>Tail</em> for a specific period when administered with proper duration dose and time relieves the clinical signs and symptoms of <em>Manyastambha</em> (cervical spondylitis) along with no side effects. <em>Shwadanstradi Tail</em> in the <em>Matra</em> of 100ml for <em>Basti</em> and <em>1 Bindu </em>(8 drops) for <em>Nasya</em> found to reduce pain, neck stiffness, tenderness, radiation of pain and numbness.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3568An Open Labelled Randomized Controlled Clinical Study to Evaluate the Effect of Vardhamana Balamoola Rasayana in Gridhrasi w.s.r to Sciatica Syndrome2025-03-15T21:13:14+08:00Anchumol Josephanchumoljoseph95@gmail.comAniruddhaanisaralaya@gmail.comShrilatha kamath Tshri9503@gmail.com<p><em>Gridhrasi</em>, a <em>Nanathmaja vata vyadi</em>, manifests in two distinct forms: <em>Vataja </em>and <em>Vata-Kaphaja</em>. Despite the availability of conventional treatments, patients often experience only temporary relief. <em>Rasayana Chikitsa</em>, a traditional approach, offers a promising long-term solution. This study aims to evaluate the effectiveness of <em>Rasayana Chikitsa</em> in managing symptoms of <em>Gridhrasi</em> and improving patient outcomes. <strong>Objectives:</strong> To evaluate the therapeutic effect of <em>Vardhamana Balamoola Rasayana</em> in <em>Gridhrasi.</em> <strong>Methodology:</strong> A randomized controlled clinical study was conducted on 30 patients, aged 18-70 years, who attended the outpatient department (OPD) of the institute with low back pain radiating to lower limbs. These patients met the diagnostic criteria and participated in the study. The participants were divided into two groups: Group A, which received <em>Vardhamana Lashuna Rasayana</em> for 16 days, and Group B, which received <em>Vardhamana Balamoola Rasayana</em> for 30 days. The treatment protocol involved mild purgation followed by incrementally increasing doses. Efficacy was assessed using both subjective criteria (pain, stiffness, functional ability) and objective criteria (Straight Leg Raise (SLR) test) at baseline, during treatment, and post-treatment. Statistical analysis was performed using paired t-tests, Wilcoxon's signed-rank tests, unpaired t-tests, and Mann-Whitney U tests to evaluate the treatment outcomes. <strong>Results:</strong> <em>Vardhamana Balamoola Rasayana</em> showed superior efficacy, with 20% achieving maximum relief. It also had higher mild relief rates (46.66% vs. 26.66%) and lesser minimum relief rates (0% vs. 40%). <strong>Conclusion:</strong> <em>Vardhamana Balamoola Rasayana</em> demonstrated superior efficacy in pain management, functional ability, and neurological deficit reduction, making it a more effective therapeutic option for <em>Gridhrasi </em>symptom relief.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3522Evaluating the Effectiveness of Duralabhadi Kashaya in the Management of Urinary Tract Infections2025-03-15T21:13:14+08:00Archana Samarchanasam1995@gmail.comArun Prataparchanasam1995@gmail.comLekshmi Rarchanasam1995@gmail.com<p>Urinary tract infections are common bacterial infection affecting the urinary tract, with a higher prevalence in females. Urinary tract infections are defined as presence and multiplication of the bacteria. Around 50% of women will be treated for atleast one urinary tract infections during their lifetime. In Ayurveda, urinary tract infections can be correlated to <em>Pittaja Mutrakrichra </em>in which <em>Vata</em> and <em>Pitta Dosha</em> are vitiated. So drugs with <em>Pittavatahara</em>, <em>Sothahara</em>, <em>Krimighna, Mutrala,</em> and <em>Vatanulomana</em> are beneficial. So <em>Duralabhadi Kashaya </em>with <em>Sitha</em> as <em>Anupana </em>mentioned in <em>Gada Nigraha</em>, <em>Mutrakrichra Prakaranam</em> having above mentioned property was selected as trial drug. The present study aims to evaluate the effectiveness of <em>Duralabhadi Kashaya</em> in the management of urinary tract infection. Subjects of all gender from 20-60, satisfying the inclusion criteria were subjected to positive sampling and total of 26 subjects were selected for the study. The selected subjects were given <em>Duralabhadi Kashaya Choorna </em>packet 48gm per day, advised to take freshly prepared <em>Kashaya</em> 48ml along with <em>Sitha </em>6gm as <em>Anupana</em> twice daily before food for 15 days and follow up was done after 15 days of treatment. Assessment of the subjects was done on 0<sup>th</sup> day, 6<sup>th</sup> day, 11<sup>th</sup> day, 16<sup>th</sup> day and follow up on 31<sup>st</sup> day with subjective and objective parameters. Based on the observations and results it has been found that subjective parameters and objective parameters got statistically significant result.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3536Effect of Mudgadi Kashaya Peya and Selected Yoga Techniques in Prediabetes2025-03-15T21:13:14+08:00Ayana N.Vayananv4759@gmail.comA.Nafeesath Beevianafeesathbeevi@gmail.comJyothi.Rdrjyothisajeev@gmail.com<p>Prediabetes, an intermediate state of hyperglycemia is the precursor stage of type 2 diabetes mellitus<strong>. </strong>Prediabetes and diabetes has been emerged as a major challenging health problem worldwide due to their high mortality and morbidity rates. Sedentary lifestyle, unhealthy diet, physical inactivity, mental stress associated with urbanisation contributes the increasing prevalence of Prediabetes and diabetes. Since type 2 diabetes and their complications results in poor quality of life and significant economic burden to family and society due to the increased medical expenditure and loss of productivity, an effective intervention is required. Life style interventions comprising a healthy diet, and physical activity in the prediabetic stage will be a best measure to halt the further progression in to type 2 diabetes. In this study an Ayurvedic diet, <em>Mudgadi Kashaya peya </em>and selected <em>yoga</em> techniques were given for a period of 90 days to evaluate their effect in Prediabetes. Statistical analysis of the data obtained revealed that <em>Mudgadi Kashaya peya</em> and selected <em>yoga</em> techniques has significant effect in reduction of FBS, PPBS, HbA1c and Total Cholesterol values.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3534Ayurvedic Management of Asthenozoospermia2025-03-15T21:13:14+08:00Asha Sreedhardravanisuresh@gmail.comAvani Suresh CKdravanisuresh@gmail.com<p>Infertility is a problem of global population and is defined as the inability to conceive even after one year of unprotected coitus. It affects about 10-15% couples and male factor is directly responsible in about 30-40% cases. Asthenozoospermia is a common cause of male infertility and is characterized by reduced sperm motility. The prevalence is 18.71% for asthenozoospremia and 63.13% for asthenozoospermia associated with Oligo-and/or teratozoospermia. According to WHO criteria 2021, asthenozoospermia is diagnosed when total motility is less than 42% or (Progressive and Non progressive) or progressive motility less than 30%. Ayurveda classics have elaborately explained about the causes of male infertility and more focus is given to the pathological conditions of <em>Sukra</em> along with its management, these are included under the concept of <em>Ashta sukradushti</em>. <em>Grandhisukradushti</em> caused by <em>Kaphavatadoshadushti </em>is one among them in which <em>Sukra</em> will be incapable to combine with the <em>Beeja </em>and it will be slowly progressive in nature thus becomes inefficient in the formation of <em>Garbha</em>, hence treatment aims at pacifying <em>Kaphavatadosha</em>. While analysing the clinical features, the condition Asthenozoospermia can be considered under <em>Grandhisukradushti</em>. A 35year old male patient attended the infertility clinic of Govt. Ayurveda College, Thiruvanathapuram, with complaints of primary infertility due to severe asthenozoospermia associated with seminal hyper viscosity since 6 years. The condition was diagnosed as <em>Grandhi sukra dushti. </em>Management focused on <em>Deepana pachana, Kaphavata hara, Srothoshodhana, Vrishya, </em>and <em>Vatanulomana. </em>Treatments given were<em> Takrapana </em>and<em> Snehapana </em>followed by<em> Virechana.</em> On follow up scan, total sperm motility was found to be improved and the patient’s female partner got conceived in the next cycle.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3543Exploring the Relationship Between Sharirika Prakriti and Medha: An Ayurvedic Perspective on Intelligence2025-03-15T21:13:14+08:00Ramesh Kumardrramesh.kaswan@yahoo.comRajesh Kumar Sharmadrramesh.kaswan@yahoo.comDinesh Chandra Sharmadrramesh.kaswan@yahoo.comPooja Pareekdrramesh.kaswan@yahoo.com<p><em>Ekavimshatika Guggulu</em> is mentioned in <em>Bhavaprakasha Madhyamakhanda Kushta Adhyaya </em>and <em>Bala Taila</em> mentioned in <em>Bhela Samhita Vata Vyadhi Adhyaya</em>. Most of the drugs in Ayurveda, a holistic medical science, emphasizes the importance of <em>Prakriti</em>, a unique concept that determines an individual's physical, mental, and socio-behavioral health. <em>Prakriti</em> is determined at the time of fertilization by the dominance of <em>Dosha</em> in <em>Shukra</em> (sperm) and <em>Shonita</em> (ovum) and remains unchanged throughout life. <em>Medha</em>, or intellect, is another crucial concept in Ayurveda that encompasses both grasping power (<em>Grahanshakti</em>) and understanding (<em>Dharanshakti</em>). This study aimed to explore the relationship between <em>Sharirika</em> <em>Prakriti</em> and <em>Medha</em> by analysing classical Ayurvedic literature, dictionaries, and research publications, as well as comparing the concept of <em>Medha</em> with the modern psychological concept of intelligence quotient (IQ). The analysis reveals that <em>Vata</em> <em>Prakriti</em> individuals have good short-term memory but poor long-term memory, while <em>Pitta</em> <em>Prakriti</em> individuals are intelligent and dominate conversations. <em>Kapha</em> <em>Prakriti</em> individuals exhibit self-control, strong faith in <em>Sastras</em>, and exceptional memory, although they take longer to grasp the subjects. The seat of the <em>Medha</em> is inferred to be the <em>Hridaya</em> (heart), as it is the location of <em>Sadhaka</em> <em>Pitta</em>, which is responsible for the manifestation of <em>Medha</em>. This study highlights the potential of integrating traditional Ayurvedic wisdom with contemporary psychological assessments to develop a more comprehensive understanding of human intelligence and cognitive functioning.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3593Ayurvedic Management of Motor Neuron Disease2025-03-15T21:13:14+08:00Surabhi G Bsurabhigb379@gmail.comGopala Krishna Gsurabhigb379@gmail.comSowmyashree U Psurabhigb379@gmail.com<p>Motor neuron disease (MND) is a neurodegenerative disorder characterized by the degeneration of both upper and lower motor neurons. Amyotrophic lateral sclerosis (ALS) is the most common form of MND. ALS is a severe neurodegenerative disorder with upper and lower motor neuron deficits in the limbs, affecting about 2 per 100,000 person/years. Brachial amyotrophic diplegia (BAD), a rare ALS variant, primarily presents with asymmetric lower motor neuron weakness, mostly affecting the upper extremities. A 75-year-old male patient diagnosed as motor neuron disease was admitted to Sri Sri College of Ayurvedic Science and Research in Bengaluru, Karnataka, on April 22, 2023 for 12 days, presenting with complaints of weakness and heaviness of both upper limbs associated with muscle wasting predominantly on right shoulder and wrist for 1 year. The clinical and laboratory features suggested a diagnosis of brachial amyotrophy diplegia, a regional variant of ALS. According to Ayurveda, <em>Avarana vatavyadhis </em>are found to have close resemblance to Motor Neuron Diseases and his symptoms can be correlated to <em>Kaphavruta Vyanavata</em>. The patient received <em>Avaranagna </em>and <em>Vata vyadhi chikitsa</em>. Assessment was done before and after treatment by using the ALSFRS-R. A satisfactory improvement was observed in the clinical findings as well as marked reduction was noted in the assessment scale. This case study suggests that brachial amyotrophic diplegia can be effectively managed symptomatically with Ayurvedic therapy.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3538Management of Vatakantaka w.s.r to Calcaneal Spur by Agnikarma2025-03-15T21:58:21+08:00Pooja Bhartipooh.210696@gmail.comAmardeep Kr. Ramanpooh.210696@gmail.comSatyendra Kr. Tiwaripooh.210696@gmail.comAkhilesh Pd. Singhpooh.210696@gmail.com<p><strong>Objectives</strong>: In today’s day to day life, prolonged hours of standing, poorly fitted and hard sole footwear, excessive walking, running and being overweight, they all are the risk factors of the calcaneal spur. There is no proper treatment in modern medicine other than surgery but Ayurveda offers a variety of treatment procedures through which patient can get relief. One of the most effective methods is <em>Agnikarma. </em>In Ayurvedic texts, similar signs and symptoms are found in a <em>Vatavyadhi</em> named <em>Vatakantaka.</em> Thus, <em>Vatashamak</em> <em>chikitsa</em> becomes the basis of the treatment. <strong>Materials and Methods</strong>: An attempt has been made in which 5 patients with calcaneal spur, confirmed by X-Ray having main complain of pain and tenderness in heel region were taken under study and <em>Agnikarma </em>were done for consecutive 3 weeks (once a week). <strong>Result</strong>: After the therapy, patient feels instant relief in the pain. <strong>Conclusion</strong>: This proves that the <em>Agnikarma</em> plays a very effective role in the management of calcaneal spur.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3541Anti-Inflammatory Potential of Punarnavadi Churna- A Polyherbal Formulation2025-03-15T21:13:14+08:00Mahendra Vishwakarmamahendravishwakarma941@gamil.comManmath K. Nandimanmath.nandi@gmail.comShruti Pandeyshruayu@gmail.com<p><em>Punarnavadi Churna</em> is a polyherbal Ayurvedic medicine traditionally used in the treatment of abdominal diseases <em>(Udar roga),</em> oedema <em>(Shotha)</em> and ulcer <em>(Vran roga)</em>. This study investigates the potential use of <em>Punarnavadi Churna</em> in managing inflammation through its key herbal ingredients, which include <em>Punarnava</em> (<em>Boerhavia diffusa</em>), <em>Haridra</em> (<em>Curcuma longa</em>), <em>Daruhaldi</em> (<em>Berberis aristata</em>), <em>Devdaru</em> (<em>Cedrus deodara</em>), <em>Haritaki</em> (<em>Terminalia chebula</em>), and <em>Kantakari</em> (<em>Solanum surratense</em>). These herbs are known for their potent anti-inflammatory properties due to the presence of active compounds that target inflammatory pathways. The primary anti-inflammatory mechanism of <em>Punarnavadi Churna</em> is its ability to inhibit pro-inflammatory cytokines and reduce oxidative stress, both of which play a significant role in inflammatory conditions. For example, <em>Punarnava</em> (<em>Boerhavia diffusa</em>) is known for its diuretic and anti-inflammatory effects, which helps to reduce inflammation and fluid retention. <em>Haridra</em> (<em>Curcuma longa</em>) contains curcumin, a powerful anti-inflammatory and antioxidant potential that has been studied a lot for its ability to reduce chronic inflammation. Other herbs such as <em>Daruhaldi</em> (<em>Barberis aristata</em>) and <em>Devdaru</em> (<em>Cedrus deodara</em>) also contribute to the ability of pain and inflammation. Research, which includes animal studies and clinical observations, has verified that <em>Punarnavadi Churna</em> is powerful in dealing with inflammatory conditions like arthritis and edema. The synergistic potential of these herbs complements their healing advantages, making <em>Punarnavadi Churna</em> a promising alternative in integrative fitness practices. Its ability to address multiple pathways of inflammation makes it a valuable natural treatment, supporting overall health and wellness through holistic, plant-based remedies.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3564A Comprehensive Analysis of Avarana in Ayurveda: Theoretical Foundations, Clinical Significance, and Therapeutic Perspectives2025-03-15T21:13:14+08:00Priya. Sdrpriya73@gmail.com<p>In Ayurvedic literature, diseases associated with <em>Vatha</em> are considered particularly serious, with Avarana being identified as a crucial pathological process in their progression. In the current social scenario, where sedentary lifestyles prevail, a majority of <em>Vatha </em>disorders can be linked to <em>Avarana</em>, though the underlying mechanisms of this association remain inadequately explored<em>. </em><em>Avarana</em> refers to the disturbed movement of <em>Vatha,</em> due to the obstruction or by other <em>Doshas</em>, <em>Dhatus</em> (tissues), <em>Malas</em> (waste products), etc. Detailed analyses of the pathogenetics of <em>Avarana</em> suggest that diverse pathological pathways contribute to the development of <em>Avarana </em>across various conditions, with clinical manifestations often dominated by the encroaching factor rather than the entrapped <em>Vatha</em>, albeit with certain exceptions. Diagnosis is achieved through meticulous symptom observation and iterative treatment trials. The general therapeutic approach for <em>Avarana </em>involves pacifying <em>Vatha</em>, cleansing the bodily channels, and addressing the encroaching <em>dosha</em>. If left untreated, <em>Avarana</em> can precipitate the progression to serious disease states. Redefining <em>Samprapti</em> through the perspective of <em>Avarana</em> paves the way for crafting more refined and effective treatment strategies, ultimately nurturing better patient well-being.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3565Bhavaprakasha Nighantu: A Comprehensive Review2025-03-15T21:13:14+08:00BS Induindusreevkm@gmail.comArya Prabhudraryaprabhu@gmail.comS Soorajaydrsooraj@gmail.com<p>The Bhavaprakasha Nighantu is a significant Ayurvedic text that serves as a bridge between classical and evolving medical traditions. Authored by Bhavamishra in the 16<sup>th</sup> century, it is a vital part of Bhavaprakasha, one of the <em>Laghutrayi</em> (three minor Ayurvedic classics). The text is distinguished by its structured classification of medicinal substances into 23 <em>Vargas</em> (groups), covering plant-based, mineral, and animal-derived drugs, as well as dietary articles. Bhavamishra's approach integrates traditional formulations with newly introduced drugs, influenced by Unani medicine and global trade, marking an important advancement in Ayurvedic <em>Dravyaguna</em> (pharmacology). A notable feature of Bhavaprakasha Nighantu is its detailed plant descriptions, including regional names, properties, actions, and therapeutic uses. Bhavamishra’s work also introduces concepts like <em>Pratinidhi Dravya</em> (substitute drugs) and emphasizes drug testing methodologies, ensuring standardization in Ayurvedic practice. His contributions significantly expanded the Ayurvedic Materia Medica, making his work a foundation for future research. The commentary by Dr. K.C. Chunekar further enhances the text’s relevance, providing botanical identification, pharmacological insights, and cross-referencing with modern science. Chunekar’s work aids in bridging Ayurveda with contemporary research, making Bhavaprakasha Nighantu a timeless reference for scholars, practitioners, and researchers. This review highlights the historical, pharmacological, and therapeutic significance of the text while underscoring its continued relevance in Ayurvedic medicine and modern botanical studies.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3558Ayurvedic and Yogic Intervention for Non-Alcoholic Fatty Liver Disease Reversal (NAFLD)2025-03-15T21:13:14+08:00Indrayani Kedar Joshidr.indrayanishrigiriwar@gmail.com<p>Non-Alcoholic Fatty Liver Disease (NAFLD) is a progressive liver disorder characterized by excessive fat accumulation, inflammation, and fibrosis, often associated with metabolic conditions like obesity, diabetes, and dyslipidemia. Conventional treatments focus on lifestyle modifications and pharmacological interventions but may not effectively halt disease progression. Ayurveda considers NAFLD as a disorder of <em>Medoroga</em> and <em>Yakrit</em> <em>Vikara</em>, primarily caused by <em>Agni Dushti</em> and imbalanced <em>Kapha-Pitta dosha</em>, leading to impaired lipid metabolism. Ayurvedic management emphasizes <em>Shodhana</em> (detoxification), <em>Deepana-Pachana</em> (digestive stimulants), <em>Yakrit Uttejaka</em> (hepatostimulants), and <em>Rasayana</em> (rejuvenation therapy), along with dietary modifications and lifestyle interventions. Yoga therapy, including <em>Asana</em>, <em>Pranayama</em>, and meditation, supports liver detoxification, enhances digestion, and improves metabolic function. This case study presents the successful management of NAFLD in a middle-aged patient through a combination of Ayurvedic therapies and Yoga. Outcome assessment was based on improvements in liver function tests, lipid profile, glycemic control, symptom relief, and ultrasound findings over an 8-week treatment period. The results suggest that an integrative approach incorporating Ayurveda and Yoga can provide effective, sustainable management of NAFLD, potentially preventing its progression to severe liver conditions.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3576Role of Rakthadushti in the Pathogenesis of Vicharchika: A Review of Classical and Keraleeya Ayurveda Perspectives2025-03-15T21:13:15+08:00Priya. Sdrpriya73@gmail.comShilpa. Pdrpriya73@gmail.com<p><em>Vicharchika</em>, classified as a <em>Kshudra kushta</em>, is a common dermatological disorder with predominant <em>Kapha dosha</em> involvement. However, <em>Raktadushti</em> plays a crucial role in its pathogenesis, as evidenced by various descriptions in Ayurvedic classics. Ayurvedic texts, including Bruhat Trayis and Keraleeya Ayurveda Granthas, highlight the interconnection between <em>Kushta, Vatarakta, </em>and<em> Rakthavatha</em>, emphasizing the role of vitiated <em>Rakta </em>in disease manifestation. Symptoms such as <em>Pidaka, Srava, Kandu, Daha, </em>and<em> Syavata</em> indicate varying degrees of <em>Rakthadushti</em>, correlating with the <em>Uthana</em> <em>avastha</em> of <em>Vatharakta</em>. The presence of <em>Paka </em>of <em>Raktha</em> further supports the similarity between <em>Vicharchika</em> and <em>Rakthavatha.</em> The treatment axis in Ayurveda revolves around <em>Hethu</em> (causative factors), <em>Linga</em> (clinical features), and <em>Oushadha</em> (medications), making the analysis of <em>Rakthadushti</em> essential for precise intervention. Therapeutic approaches such as <em>Rakthamokshana</em>, <em>Sodhana</em> (purification), and <em>Samana</em> (palliative measures) play a key role in disease management. Keraleeya Ayurveda texts, including <em>Chikitsa Manjari</em> and <em>Arogyaraksha kalpadruma</em>, provide additional insights into the pathology and treatment of <em>Vicharchika</em> through the concept of <em>Rakthavatha</em> and <em>Rakthasthambha</em>. A comprehensive understanding of <em>Rakthadushti </em>enables effective treatment planning, ensuring holistic management and better clinical outcomes in <em>Vicharchika</em>.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Researchhttp://ijaprs.com/index.php/ijapr/article/view/3524Literature review of Vasa in various Ayurvedic treatise2025-03-15T22:28:54+08:00Bhatnagar Alpanaalp.bhatnagar@gmail.comMarde Ramakantramakant.marde@divyayoga.comSoni Priyankadrtarunsharma392@gmail.comGitikagitikasingla10@gmail.comVarshney Akshayakshayvarshneydr@gmail.com<p><em>Adhatoda vasica Nees.,</em> also known as Malabar nut or <em>Vasa</em>, has long been utilized in traditional medicine for its potent respiratory therapeutic properties. This plant has been used for 2000 years to treat respiratory problems. The leaves of this plant give a stimulant effect on the respiratory system. In <em>Ayurveda</em> medicinal system it is considered a potent herb to cure diseases like cough, symptoms of cold, asthma, bronchitis. <em>Vasa</em> is said to have <em>Tikta </em>and <em>Katu </em>in <em>Rasa</em> and <em>Sheet</em> in <em>Veerya </em>it has <em>Katu Vipaka </em>and is said to have <em>Kapha-Pittahara </em>property. <em>Vasa </em>was reviewed in various text like <em>Veda, Samhita, Kosha Grantha</em>. <em>Vasa </em>was found to be as the main ingredient of many formulations in the treatment of <em>Raktpitta</em>, <em>Kaphaj Vikar, Vataj Vikar</em>, and other respiratory diseases. <em>Vasa Swarasa </em>was found in various formulations used as <em>Bhawana Dravya</em>, also various <em>Paryaya</em>, <em>Guna, Karma </em>and different opinions of <em>Acharyas </em>in various <em>Samhitas </em>were observed.</p>2025-03-07T00:00:00+08:00Copyright (c) 2025 International Journal of Ayurveda and Pharma Research